Navigation Links
The Two-In-One Estrogen Therapy For Managing Menopause And Maintaining Healthy Skin

Menopause is a normal part of life. It is one step in a long, slow process of reproductive aging. For most women this process begins silently somewhere around age 40 and declining levels of the hormones estrogen and progesterone // is responsible for physiological and emotional changes in a female.

Menopause, or the “change of life,” affects each woman in a different way. In an attempt to help women cope up better with menopause, hormone replacement therapy is instituted and numerous studies and debates have been conducted on the advantages and disadvantages of the same.

Long-term hormone therapy used earlier in menopause has been found to be associated with fewer wrinkles and less skin rigidity in postmenopausal women, and may have cosmetic benefits according to a new study.

Hormone therapy, if started early can be a key to the prevention of wrinkles by maintaining the elasticity of the skin. They found that rigidity was significantly decreased in hormone therapy users compared to nonusers at both the cheek (1.1 vs. 2.7) and forehead (20 vs. 29).

Just as it is said, ”the skin is a mirror of the inner health” what is happening in the skin may be reflective of the functioning of other organs such as the heart and bone, which might also be benefiting from estrogen therapy. The fact that hormones can maintain a healthy skin but cannot reverse existing damage has to be borne in mind
'"/>




Page: 1

Related medicine news :

1. Estrogen lowers cancer risk
2. Estrogen Does Not Prevent Recurrent Strokes
3. Herbs With Estrogen Action Aggravate Cancer Risk
4. Osteoarthritis and Estrogen are connected
5. Estrogen Patch is Safer than Pills for Heart
6. Estrogen in Food Reduces Cancer Risk
7. Estrogen Found To Protect the Colon Against Cancer
8. The Side Effects Of Estrogen Therapy
9. The Effects Of Estrogen Therapy
10. A Likely Use For Estrogen Therapy
11. Preventing Colon Cancer With Estrogen
Post Your Comments:
(Date:10/6/2008)... Millions of women suffer with symptoms of men...conomic rescue plan. But the effects of our curren...aking it increasingly difficult for U.S. women to ...kstead announces new cost effective drug-free guid...a prescription. , Las Veg...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: ...ed SAP as senior vice president,of the Healthcare ...e,August 1, 2008, Mr. Papandrea will help drive SA...egic software solutions to healthcare,organization...onjunction,with the 3rd annual Ambassadors Dinner ...
(Date:10/5/2008)...e blood test may help detect serious bacterial inf...lood stream infections in young infants who come t...ave no clear cause. Researchers at Children,s Hosp...eorge Washington University, show that a new diagn...y infants at high risk for SBIs while potentially ...
(Date:10/5/2008)...ittle exercise goes a long way toward helping seve...fe and complete important daily tasks, according t... , In a pre-program assessment where patients re...e per week, individuals who were more active repor...rted improvements in their ability to perform dail...
Breaking Medicine News(10 mins):Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3Health News:New test could help catch serious infections in babies 2Health News:A little exercise goes a long way for severely obese 2
...lds of academia, research, government and industry...of-the-art// communications technology can make he...an emerging field that encompasses a range of heal...ectronic medical records, telemedicine, citizen-or...
...the National Rural Health Mission (NHRM) of India ...ogrammes.// The funds will be allocated through U...pecific activities. The governments of India and ...i-partner initiative Tuesday here for achieving th...
...and those affected by HIV/AIDS, a Community Based ...ai Vizhuthugal' (Tamil Nadu AIDS Initiative Roots)...m Coimbatore, Madurai, Vellore, Salem and Chennai,...g the community to undertake and develop skills fo...
...al to expand price control from 74 to 354 drugs in...dustry chamber CII today said the step will prove ...as the economy. "Healthy competition between phar...le pricing. Instead of affecting the growth by ove...
Other Medicine News:Health News:Delhi to Host E-health Global Meet Next Month 2Health News:Norway Grants $80 mn to India's Health Mission 2
(Date:10/3/2008)... REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCall/...ed the filing of an investigational new drug,(IND)...molecule modulator,of phosphodiesterase 4 (PDE4), ...e compound is being developed as a new and potenti...y loss and cognitive deficits associated,with Alzh...
(Date:10/2/2008)...The Study Will Compare the Results of Rosetta Geno...hich Differentiates Squamous From non Squamous ...tic Methods, A Test Based on the miRview(TM) Techn...olumbia University,s High Complexity Molecular Pat...Year, Rosetta Genomics is Expecting to Launch miR...
(Date:10/2/2008)... GOTEBORG, Sweden, October 2 /- Calab... dose study in xerostomia ("dry mouth"),patients h...studied in 45,dry mouth patients between the ages ...ct a dose for evaluation in a succeeding Phase III... the cholinesterase inhibitor,physostigmine. It is...
(Date:10/2/2008)... Data Indicate Dual Modes of Action and Synergy ...stCall/ -- Access Pharmaceuticals, Inc.,(OTC Bulle...clinical,studies on Angiolix showing that by block...nic effect as well as a direct anti-proliferative ... of human breast cancer (MX-1),Angiolix had a sig...
Breaking Medicine Technology:deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3Pancreatic Cancer Biomarkers Found 21825 1Pancreatic Cancer Biomarkers Found 21825 2Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 1Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 230 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 130 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 2Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 1Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 2
...HMOND, Va.--(BUSINESS WIRE)--May 3, 2007 - Insmed ...s from a Phase II,investigator-sponsored study of ...otonic muscular dystrophy (DM1)., Preliminary resu...University of Rochester School of Medicine and Den...oses of IPLEX up to 1,mg/kg/day in six patients me...
...ding Symbol: QPT: TSX Venture Exchange, EDMONTON, ...Tech,Inc. ("Quest" or the "Company") Quest is plea...opment of SL052 for the treatment,of prostate canc...of cancer death in,American men with approximately...rent therapeutic modalities for localized prostate...
Other Medicine Technology:Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3
Bacon Bone Rongeur
Schell Rongeur
Zaufal-Jansen Ronguer
Ruskin Mini-Bone Rongeur
Medicine Products: